Understanding Your Papilloma Diagnosis
At a Glance
An intraductal papilloma is a noncancerous growth inside a breast milk duct, not breast cancer. Next steps depend on whether the biopsy shows abnormal cells, matches the breast imaging, and explains symptoms; regular imaging or removal may be recommended.
Receiving a biopsy result that mentions a “growth” or “lesion” in your breast can be deeply unsettling. Many patients experience a wave of fear, immediately thinking of breast cancer—especially if the diagnosis was prompted by a palpable lump or the alarming sight of bloody nipple discharge [1][2]. It is important to know that an intraductal papilloma is fundamentally a benign (non-cancerous) condition [3]. While it requires careful evaluation, it is a common finding and is not a breast cancer diagnosis.
What is an Intraductal Papilloma?
In plain language, an intraductal papilloma is a small, wart-like growth that develops inside a milk duct [1]. Think of it like a tiny skin tag, but located within the plumbing of the breast. These growths are made of fibrous tissue and blood vessels, covered by a layer of the same cells that line the milk ducts [3]. Because they are fragile and have a rich blood supply, they can easily bleed or leak fluid, which is why they often cause nipple discharge [4].
Central vs. Peripheral Papillomas
Doctors often categorize these growths based on where they are located in your breast. While they are the same type of growth, their location often determines how they are found and the symptoms they cause.
Central Papillomas
- Location: Found in the large milk ducts just behind or near the nipple (the retroareolar area) [5].
- Signs: These are a common cause of spontaneous nipple discharge, which may be clear, yellow, or bloody [4]. They may also be felt as a small, moveable lump near the nipple [5].
- Discovery: Often found because the patient notices symptoms that lead to an ultrasound or mammogram.
Peripheral Papillomas
- Location: Found in the smaller ducts deeper in the breast tissue, further away from the nipple [5].
- Signs: These are often “silent,” meaning they cause no symptoms and cannot be felt [5].
- Discovery: Most often found incidentally during a routine mammogram as a small mass or a cluster of microcalcifications (tiny calcium deposits) [5]. These are more likely to be “multiple,” meaning more than one growth is present [6].
Understanding Your Biopsy Results
A biopsy is a small sample, and your care team’s primary goal is to ensure the sample represents the entire area. Pathologists look for specific “markers” under the microscope to confirm the diagnosis.
Benign vs. Atypical
The most important word to look for in your report is atypia (specifically atypical ductal hyperplasia or ADH, or ALH).
- Benign Papilloma: The cells in the growth look normal. The risk of this area “upgrading” to cancer after it is fully removed is low, estimated at approximately 5% in study cohorts [7].
- Atypical Papilloma: The growth contains some abnormal-looking cells. This is considered a higher-risk finding. Because a biopsy only takes a small piece, there is a higher chance (roughly 36% in pooled data) that more advanced cells might be present nearby [7].
The Role of Staining
Pathologists often use special “dyes” called immunohistochemistry (IHC) to verify the diagnosis. They look for myoepithelial cells, which act like a protective layer around the duct [8]. While seeing these cells supports a benign or in-situ interpretation, it does not by itself prove a lesion is benign; pathologists rely on architecture and morphology as well [9][10].
Why “Concordance” Matters
Your doctor will check if the biopsy result is concordant [11]. This simply means: does the pathology report (what the cells look like) match the radiology (what the mammogram/ultrasound showed)?
- If you have a 1cm mass on ultrasound and the biopsy shows a benign 1cm papilloma, the results are concordant.
- If the imaging showed something suspicious but the biopsy only found a tiny, unrelated fragment of a papilloma, the results may be “discordant,” and your doctor may recommend removing the area to be certain nothing was missed [12].
What Happens Next?
Management is increasingly personalized. If your papilloma is small, causes no symptoms, and shows no atypia on biopsy, your doctor may offer surveillance (watching it with regular imaging) rather than surgery [13][14]. However, if there is atypia, or if the growth is causing bothersome symptoms like bloody discharge, surgical removal is usually the standard recommendation to ensure a complete and accurate diagnosis [7][15]. Removal can sometimes be performed with a large-core vacuum needle (vacuum-assisted excision) rather than traditional surgery [16].
Quick Glossary
- BI-RADS: A standard score used by radiologists to describe imaging suspicion, not a cancer diagnosis.
- Concordant: The pathology successfully explains the imaging finding.
- Discordant: The biopsy results do not match the level of suspicion on imaging.
- DCIS (Ductal Carcinoma In Situ): Non-invasive, stage 0 breast cancer confined to the milk ducts.
- ADH / ALH: Atypical Ductal/Lobular Hyperplasia (abnormal, non-cancerous cells).
- VAE: Vacuum-Assisted Excision (a minimally invasive procedure using a specialized biopsy needle).
Common questions in this guide
What is an intraductal papilloma?
Does an intraductal papilloma mean I have breast cancer?
What does atypia mean on a papilloma biopsy?
What does a concordant breast biopsy mean?
Do all intraductal papillomas need to be removed?
Can an intraductal papilloma be removed without open surgery?
Are central and peripheral papillomas different?
Get notified when new evidence is published on intraductal papilloma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Unusual presentation of intraductal papilloma on the nipple: A case report.
Rahman NA, Arnaout I, Krimsti M, et al.
International journal of surgery case reports 2024; (117()):109483 doi:10.1016/j.ijscr.2024.109483.
PMID: 38493616 - 2
Bloody nipple discharge due to intraductal papilloma in an adolescent girl.
Ostertag-Hill CA, Wang Y, Nickolich S, Wiggins DL
BMJ case reports 2023; (16(3)) doi:10.1136/bcr-2022-254177.
PMID: 36878614 - 3
Mammographic and Sonographic Findings of Intraductal Papilloma of the Right Breast: A Case Report.
Hodge E, Mirchandani A, Shah B
Cureus 2023; (15(4)):e37034 doi:10.7759/cureus.37034.
PMID: 37143645 - 4
Classical Lobular Carcinoma In Situ Arising From an Intraductal Papilloma of the Breast: A Case Report.
Kim NI, Park MH, Lee JS
International journal of surgical pathology 2021; (29(5)):534-537 doi:10.1177/1066896920985216.
PMID: 33403884 - 5
Papillomas of the breast: factors associated with underestimation.
Boufelli G, Giannotti MA, Ruiz CA, et al.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(4)):310-314 doi:10.1097/CEJ.0000000000000343.
PMID: 28296665 - 6
Treatment Strategy for Breast Benign Intraductal Papilloma: A Meta-Analysis.
Lou C, Wang W, Zhou B
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2024; (43(3)):39-49 doi:10.1615/JEnvironPatholToxicolOncol.2024052888.
PMID: 38608144 - 7
Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
Zhang X, Liu W, Hai T, Li F
Annals of surgical oncology 2021; (28(13)):8643-8650 doi:10.1245/s10434-021-10188-7.
PMID: 34331160 - 8
Immunohistochemistry for diagnosis and prognosis of breast cancer: a review.
Bonacho T, Rodrigues F, Liberal J
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2020; (95(2)):71-91 doi:10.1080/10520295.2019.1651901.
PMID: 31502889 - 9
Pathology of breast papillary neoplasms: Community hospital experience.
Vdovenko AA
Annals of diagnostic pathology 2020; (49()):151605 doi:10.1016/j.anndiagpath.2020.151605.
PMID: 32920473 - 10
Papillary lesions of the breast - review and practical issues.
Ni Y, Tse GM
Seminars in diagnostic pathology 2022; (39(5)):344-354 doi:10.1053/j.semdp.2022.06.001.
PMID: 35718581 - 11
Risk of malignancy in papillary neoplasms of the breast.
Liu C, Sidhu R, Ostry A, et al.
Breast cancer research and treatment 2019; (178(1)):87-94 doi:10.1007/s10549-019-05367-w.
PMID: 31332665 - 12
Papillary Neoplasms of the Breast: WHO Classification, Multimodality Imaging, and Radiologic-Pathologic Correlation.
Thai JN, Vickery J, Boyraz B, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(8)):e240091 doi:10.1148/rg.240091.
PMID: 40674246 - 13
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
Nakhlis F, Baker GM, Pilewskie M, et al.
Annals of surgical oncology 2021; (28(5)):2573-2578 doi:10.1245/s10434-020-09215-w.
PMID: 33047246 - 14
Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
Keating N, Cevik J, Hopkins D, Lippey J
Journal of surgical oncology 2024; (129(6)):1025-1033 doi:10.1002/jso.27592.
PMID: 38305061 - 15
Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H, Bomeisl P, Amin AL, et al.
Human pathology 2022; (128()):90-100 doi:10.1016/j.humpath.2022.07.012.
PMID: 35863513 - 16
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C, Leo C, Kubik-Huch RA, et al.
Virchows Archiv : an international journal of pathology 2023; (483(1)):5-20 doi:10.1007/s00428-023-03566-x.
PMID: 37330436
This page is for informational purposes only and does not constitute medical advice. Your breast care team should interpret your biopsy, imaging concordance, and treatment options for your specific situation.